USD 25.72
(1.94%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | 2.04 Million USD | -33.34% |
2023 | 3.07 Million USD | -64.66% |
2022 | 8.69 Million USD | 3.93% |
2021 | 8.37 Million USD | -61.14% |
2020 | 21.54 Million USD | -28.96% |
2019 | 30.31 Million USD | 50.8% |
2018 | 20.1 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q4 | 2.04 Million USD | -70.81% |
2024 Q1 | 6.94 Million USD | 154.9% |
2024 Q2 | 8.27 Million USD | 19.08% |
2024 FY | 2.04 Million USD | -33.34% |
2024 Q3 | 7.01 Million USD | -15.14% |
2023 Q1 | 6.94 Million USD | -20.15% |
2023 FY | 3.07 Million USD | -64.66% |
2023 Q4 | 3.07 Million USD | -27.28% |
2023 Q3 | 4.22 Million USD | -24.06% |
2023 Q2 | 5.56 Million USD | -19.87% |
2022 Q4 | 8.69 Million USD | 39.16% |
2022 Q2 | 7.01 Million USD | -3.08% |
2022 FY | 8.69 Million USD | 3.93% |
2022 Q3 | 6.25 Million USD | -10.83% |
2022 Q1 | 7.23 Million USD | -13.58% |
2021 Q3 | 26.59 Million USD | 8.45% |
2021 Q1 | 23.28 Million USD | 8.09% |
2021 FY | 8.37 Million USD | -61.14% |
2021 Q4 | 8.37 Million USD | -68.53% |
2021 Q2 | 24.52 Million USD | 5.34% |
2020 Q4 | 21.54 Million USD | 1.0% |
2020 FY | 21.54 Million USD | -28.96% |
2020 Q3 | 21.32 Million USD | -0.84% |
2020 Q2 | 21.5 Million USD | -40.3% |
2020 Q1 | 36.02 Million USD | 18.82% |
2019 Q4 | 30.31 Million USD | 0.0% |
2019 FY | 30.31 Million USD | 50.8% |
2019 Q1 | - USD | 0.0% |
2018 FY | 20.1 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Well Corporation | 8.2 Million USD | 75.03% |
Doximity, Inc. | 12.39 Million USD | 83.472% |
Evolent Health, Inc. | 635.05 Million USD | 99.677% |
MultiPlan Corporation | 4.53 Billion USD | 99.955% |
Teladoc Health, Inc. | 1.58 Billion USD | 99.87% |
Veeva Systems Inc. | 46.44 Million USD | 95.588% |